CHRISTINE BELLMAN: Open Payments
NPI 1205269859 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 21 payments from 16 companies in 2025. Trend: 2023 $537 · 2024 $634 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $164 |
| Corcept Therapeutics | 2 | $47 |
| Dexcom, Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $35 |
| Lilly USA, LLC | 1 | $27 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Phadia US Inc. | 1 | $20 |
| Abbott Laboratories | 1 | $19 |
Products named: REPATHA, Korlym, Dexcom G6 Transmitter, JARDIANCE, TZIELD, VOQUEZNA, XIFAXAN, EVENITY.
Industry payments across TX — which companies pay providers there.
